How to Dispute a False Positive Lab Result

作者： 翠盖调味研发团队 出版：广东独特风味有限公司 最后更新：  十月 27，2026 WhatsApp与Telegram： +86 189 2926 7983 电子邮件：info@cuiguai.com   A false positive laboratory result can stop a shipment, trigger a recall, void a supply agreement or end a retail listing within days. For flavor houses and e-liquid manufacturers, the most dangerous moment is not the arrival of the report itself but the following seventy-two hours, when an unmanaged response hardens into a permanent commercial record. A disputed result that is handled procedurally can usually be resolved with a retest and a corrected report. The same result handled emotionally becomes a regulatory finding that follows the product for years.   This guide explains where false positives actually come from, which test methods generate them most often, and how to construct a dispute file that laboratories, customers and regulators take seriously. The aim is not to teach anyone how to avoid a legitimate detection. It is to give technical and quality managers the vocabulary and the documentary discipline they need when a result is wrong, because in analytical chemistry the party with the better evidence almost always wins the argument.   One principle should frame everything that follows: a laboratory report is an opinion supported by data, not a verdict. It can be tested, challenged and, when it is wrong, corrected. The right to challenge it is written into most accreditation standards and into every competent analytical method, and exercising that right professionally is a normal part of operating a regulated manufacturing business. False Positive Investigation

Why False Positive Results Happen

A false positive is a reported detection of a substance that is not present in the sampled material at or above the method's stated confidence level. It is distinct from a false negative, and it is distinct from a sampling error in which the reported result accurately describes a contaminated or mislabeled sample. Getting that distinction right at the start determines which dispute route is available, so the first task is always to establish what the laboratory believes it measured and why.  

Contamination Sources in the Testing Chain

Contamination is the single most common cause, and it usually happens before the sample reaches the instrument. Shared glassware that previously held a high-concentration standard, septum particles from an autosampler vial, carryover from the preceding injection in an analytical sequence, and laboratory air in a facility that also handles nicotine standards can all introduce a signal. A result that sits just above the reporting threshold, appears in a blank, or reproduces only when the sample is injected immediately after a calibration standard is a classic contamination signature rather than a formulation problem.   There is also a category of contamination that originates on the manufacturing side, which is why a dispute must examine the production record as well as the laboratory record. Residue in a shared mixing vessel, a changeover that did not include a validated cleaning step, an incorrectly labelled retained sample, or a bulk container that was flushed but not verified can all produce a genuine detection in a sample that does not represent the finished product as designed. Identifying which of these has occurred is not about assigning blame; it determines whether the correct remedy is a retest, a reformulation, or a cleaning-validation project.  

Analytical Limits: LOD, LOQ and Matrix Effects

Every method has a limit of detection and a limit of quantification, and those two numbers are not the same. The limit of detection is the lowest amount that can be reliably distinguished from noise. The limit of quantification is the lowest amount that can be measured with acceptable precision and accuracy. A report that cites a detection between the two limits is reporting an identification that the method was never validated to quantify, and that single fact is often enough to compel a laboratory to qualify or withdraw the finding.   Matrix effects compound the problem. An e-liquid is a complex mixture of propylene glycol, vegetable glycerin, water, nicotine, acids and aroma chemicals, and the ionization behavior of a target analyte in that matrix can differ substantially from its behavior in a clean solvent standard. Methods that are validated only in solvent, then applied to a flavored matrix, can produce signal enhancement or suppression that mimics a real detection. A properly validated method demonstrates recovery in the actual matrix across the relevant concentration range, and asking for that validation data is a legitimate and highly effective line of inquiry.  

Sampling and Chain-of-Custody Failures

A sample is only as trustworthy as its provenance. Common failures include an unsealed container, a lid that was opened during transport, a label applied in pencil or with an ambiguous product code, a temperature excursion, a sampling point that was not recorded, and a field blank that was never collected. In a formal dispute, a broken chain of custody does not automatically invalidate a result, but it shifts the evidentiary burden onto the party that wants to rely on it. For manufacturers, the practical control is to insist on a written sampling protocol before any third party takes a sample, to receive a photographic record of the sealed container and its label, and to receive the corresponding field or transport blank results alongside the sample results. These requests cost nothing and are routine in accredited practice. A laboratory that resists them is signaling something about the robustness of its procedures that is useful to know before the report is used in a commercial decision. Sample Chain of Custody

Which Tests Produce False Positives Most Often

Not all panels carry the same risk. Understanding which tests are vulnerable, and why, lets a manufacturer prioritize its response and avoid spending an entire dispute budget on the wrong argument.

Nicotine and Synthetic Nicotine Assays

Nicotine quantification is highly reliable when performed by a validated chromatographic method with an internal standard, and highly error-prone when it is performed by a rapid immunoassay or a colorimetric screen. Immunoassays are designed for speed and are known to cross-react with structurally similar alkaloids and with some aroma constituents. A screening result should never be treated as a quantitative finding; the correct response is to request confirmatory analysis by a chromatographic method, ideally with mass spectrometric detection, and to compare the reported concentration against the label claim with an appropriate tolerance.   Synthetic nicotine introduces a specific complication. Because the synthetic and tobacco-derived molecules are chemically identical, differentiation depends on minor alkaloid profiles or on isotopic signatures, and the methods are younger and less standardized. Laboratories occasionally over-interpret trace signals from tobacco-derived material as evidence of a synthetic origin, or vice versa. Where a report makes an origin claim, the dispute should focus narrowly on the discriminative power of the method, the reference materials used, and whether a validated threshold for the diagnostic ratio was established.

VOC, Diacetyl and Carbonyl Panels

Volatile organic compound panels and carbonyl analyses are the most frequent source of contested detections in flavor testing, for a structural reason: many target analytes are also ambient laboratory contaminants or degradation products formed during the analysis itself. Carbonyls such as formaldehyde and acetaldehyde can be generated in situ by thermal decomposition of the aerosol matrix. Diacetyl and related diketones can be introduced by the solvents and consumables used in the method. A detection that appears in the method blank, or that scales with the age of the sampling train rather than with the sample, points to analytical artifact.   The defensible inquiry is procedural. Ask for the method blank and the reagent blank results, the sampling duration and temperature, the derivatization reagents and their lot numbers, and the storage interval between collection and analysis. Carbonyl samples that were stored beyond the validated holding time often show inflated results, and most validated methods specify that holding time explicitly. If the report does not state it, that omission is itself a legitimate basis for requesting a re-analysis.

Heavy Metals and Elemental Impurities

Elemental analysis by inductively coupled plasma techniques is generally robust, but it is vulnerable to two specific failure modes. The first is contamination from grinding, sieving or digestion equipment, which can introduce chromium, nickel or zinc at concentrations that exceed a limit. The second is spectral interference in the absence of appropriate collision or reaction cell conditions, which can inflate a result for one element from the signal of another. Both are identifiable from the raw spectra and from the digestion blank data, and both have established corrective approaches.   For elemental disputes, request the digestion blank, the spiked recovery sample, the interference-correction settings and the calibration range relative to the reported value. A reported result that falls outside the calibrated range, or that was obtained without an interference check, is technically weak regardless of the analytical technique's general reputation. Reviewers who understand this will also recognize a properly defended result, which is precisely why the same evidence pack serves both attack and defense.

Building a Dispute File: Step by Step

A dispute is won on structure. The following four steps form a sequence in which each one generates the evidence the next one needs, and each one produces a document that can be shared with a customer or an authority without further editing.

Step 1 - Request the Raw Data, Not a New Certificate

Send a written, specific and non-accusatory request within one business day of receiving the report. Ask for the chromatograms or spectra, the calibration curve with residuals, the method blank and reagent blank results, the instrument tuning and sequence files, the sample preparation record including weights and dilutions, the method validation summary covering the relevant matrix and range, the limits of detection and quantification, and the analyst's and reviewer's qualifications against the method. Specify a format, such as native instrument files or a signed PDF export, and a response deadline.   Do not ask for a re-issue of the certificate at this stage. A re-issued certificate without underlying data tells you nothing about whether the original finding was sound, and it closes the window in which the raw data can be reviewed. Keep the request narrow and technical, and copy the customer or importer who authorized the test so that all parties see the process is being handled professionally rather than defensively.

Step 2 - Commission an Independent Confirmatory Retest

Simultaneously, arrange an independent analysis of the retained sample from the same production lot, using a different laboratory with the relevant accreditation for the disputed parameter. The retest should use a method of higher specificity where possible, for example mass spectrometric confirmation in place of a spectroscopic screen, and it should include both the manufacturer's retained sample and a split of the disputed sample if one is available. Testing both is what allows you to distinguish a product problem from a sample-handling problem.   Handle the retest as if it will be disclosed. Use a documented chain of custody, record the shipping temperature, photograph the seals before and after transport, and instruct the laboratory in writing to report any anomaly. An independent report that includes a chain of custody, a validated method with stated limits and a reference to an accreditation scope is persuasive to customers, insurers and regulators alike. An informal retest arranged by telephone is not.

Step 3 - Challenge Methods, Accreditation and Scope

Verify that the original laboratory was accredited for the specific test performed, within the stated scope, at the time of analysis. Accreditation is parameter-specific and is periodically revised; a laboratory that is accredited for one method is not thereby competent in an unrelated one. Check whether the method was validated for the relevant matrix, whether the reported value exceeds the validated limit of quantification, and whether the laboratory applied any dilution that would change the uncertainty statement.   Then examine the interpretation rather than the measurement. Confirm that the correct regulatory threshold was applied, that the units and reporting basis match the specification, and that a screening result was not presented as a quantitative determination. A significant proportion of contested reports are correct analytically but wrong in interpretation, which is the easiest class of dispute to resolve because it requires only a corrected statement rather than a new analysis.

Step 4 - Escalate Through the Right Channel, in Writing

If the data do not resolve the issue, escalate in a defined order. First, request a formal technical review by the laboratory's quality manager, citing the specific deficiency and the documentary basis for it. Second, if the laboratory is accredited, you may ask the accreditation body to confirm the scope, or request information about how a complaint against the accredited result should be lodged. Third, where a regulator has relied on the result, respond through the administrative process that applies to that authority, referencing your evidence pack and requesting a confirmatory analysis.   Keep the tone factual throughout. Correspondence should state the report reference, the disputed value, the specific technical basis for the challenge, the evidence attached, and the outcome sought, in that order. Complaints about commercial inconvenience or reputational harm belong in a separate commercial discussion; mixing them into a technical dispute weakens the technical case and gives the other side an easy way to characterize your position as dissatisfaction rather than error. Analytical Data Review

Documentation That Wins Disputes Before They Start

The manufacturers who rarely lose disputes are not better at arguing. They are better at keeping records, and their records are structured so that a query can be answered in hours rather than weeks.

Safety Data Sheets and Formulation Records

The safety data sheet is the first document any reviewer will open, and Section 3 composition is where a disputed substance claim will be tested. A sheet that lists components precisely, in the correct concentration ranges, with consistent revision control and an accurate hazard classification, establishes that the manufacturer understands its own formulation. Ambiguity here invites a broader investigation, including a demand for a full manufacturing formula, which is a commercially undesirable outcome that a well-drafted sheet prevents. Our walkthrough of SDS Sections 2 and 3 for flavors covers exactly the checks an external reviewer performs on those two sections.   Behind the sheet, maintain a controlled formulation record for each concentrate: component identities and CAS numbers, supplier and lot references, the approved specification with tolerances, and a version history linked to any regulatory notification in force. When a disputed result names a specific substance, the manufacturer should be able to state within an hour whether that substance is a declared component, a trace contaminant, or absent from the formulation as designed, and to support that statement with a signed record.

Unique Formula Identifiers and Traceability

Where a product is notified through a poison centre system, the Unique Formula Identifier is the hinge between the commercial product and the regulatory dossier. Because a new UFI is required when a composition change alters the hazardous-mixture classification, the identifier history is also an audit trail of reformulation. That trail is directly useful in a false positive dispute, because it shows the exact composition that was on the market on the date the sample was taken. Our explanation of UFI codes for European poison centres sets out when a re-notification is triggered, and the same logic applies in any jurisdiction that maintains a formula registry. Pair the identifier with batch traceability that actually works under pressure. A lot code on the retail unit should resolve to a filling record, a concentrate lot, a component lot series and a retained sample. Test the chain by running a traceability exercise once a quarter using a random finished unit, and time how long it takes to produce the full record. If the answer is measured in days, the chain has gaps, and those gaps will be used against you in exactly the dispute where the analytical evidence is genuinely inconclusive. Compliant Batch Control

Preventing the Next False Positive

Prevention is cheaper than dispute, and most of the measures that prevent contested results also improve ordinary quality performance. Establish a written sampling protocol with your testing partners, define which method is authoritative for each restricted parameter, and require confirmatory chromatographic analysis before any screening result is reported as a finding. Then verify that requirement in your supplier agreements rather than leaving it to goodwill.   Build reference benchmarks into the range. Broad, well-characterized profiles such as an orange flavor concentrate和一款 vanilla cream flavor are useful anchors for an internal control program, because a stable reference product allows a laboratory's results to be compared against a documented historical baseline. When a reported value departs sharply from that baseline without a corresponding production change, the anomaly is visible immediately, and a retest can be requested before the report is circulated.   Finally, treat every dispute as a system improvement. Record the root cause, whether analytical, procedural or interpretive, and feed the finding back into the sampling protocol, the method specification and the training record. A manufacturer that has resolved three disputes and updated its controls each time will find that the fourth report is accurate, defensible and, most importantly, expected.   For batch documentation, retained-sample support and confirmatory testing coordination, contact our technical team: 📞 电话： +86 0769 8838 0789 🌐 网站： https://www.cuiguai.com 📧 电子邮件： info@cuiguai.com 💬WhatsApp与Telegram： +86 189 2926 7983

参考文献

U.S. Food and Drug Administration. Bioanalytical Method Validation - Guidance for Industry (method validation, limit of detection and limit of quantification). https://www.fda.gov/regulatory-information/search-fda-guidance-documents   Eurachem. The Fitness for Purpose of Analytical Methods: A Laboratory Guide to Method Validation and Related Topics, 2nd edition. https://www.eurachem.org/index.php/publications/guides/mv   International Organization for Standardization. ISO/IEC 17025 - General requirements for the competence of testing and calibration laboratories. https://www.iso.org/standard/66912.html   U.S. Centers for Disease Control and Prevention. Laboratory Quality Assurance and Standardization Programs - chain of custody and specimen integrity guidance. https://www.cdc.gov/labquality/index.html